Colgate-Palmolive Company [NYSE: CL] gained 0.45% on the last trading session, reaching $78.70 price per share at the time. The company report on June 9, 2022 that Colgate Declares Regular Quarterly Dividend.
Top 5 Cheap Stocks to Own Right Now
While finding safe stocks with the potential for monster gains isn't always easy, we've found a few that could pay out well. In fact, within our report, "Top 5 Cheap Stock to Own Right Now", we have identified five stocks we believe could appreciate the most even if you just have $1,000 to invest.
Sign up here to get your free report now. .
The Board of Directors of Colgate-Palmolive Company (NYSE:CL) today declared a quarterly cash dividend of $0.47 per common share, payable on August 15, 2022, to shareholders of record on July 21, 2022. The Company has paid uninterrupted dividends on its common stock since 1895.
Colgate-Palmolive Company represents 840.60 million in outstanding shares, while the company has a total market value of $66.88 billion with the latest information. CL stock price has been found in the range of $78.09 to $78.99.
If compared to the average trading volume of 5.23M shares, CL reached a trading volume of 5457538 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here is what top equities market gurus are saying about Colgate-Palmolive Company [CL]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for CL shares is $81.63 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on CL stock is a recommendation set at 2.80. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Atlantic Equities have made an estimate for Colgate-Palmolive Company shares, keeping their opinion on the stock as Neutral, with their previous recommendation back on May 03, 2022. While these analysts kept the previous recommendation, Raymond James raised their target price to Mkt Perform. The new note on the price target was released on April 08, 2022, representing the official price target for Colgate-Palmolive Company stock. Previously, the target price had yet another raise to $83, while Bernstein analysts kept a Mkt Perform rating on CL stock. On January 31, 2022, analysts decreased their price target for CL shares from 78 to 76.
The Average True Range (ATR) for Colgate-Palmolive Company is set at 1.59, with the Price to Sales ratio for CL stock in the period of the last 12 months amounting to 3.83. The Price to Book ratio for the last quarter was 207.11, with the Price to Cash per share for the same quarter was set at 1.10. Price to Free Cash Flow for CL in the course of the last twelve months was 78.68 with Quick ratio for the last quarter at 0.70.
Trading performance analysis for CL stock
Colgate-Palmolive Company [CL] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -3.99. With this latest performance, CL shares gained by 1.07% in over the last four-week period, additionally sinking by -7.04% over the last 6 months – not to mention a drop of -4.53% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for CL stock in for the last two-week period is set at 50.41, with the RSI for the last a single of trading hit 48.00, and the three-weeks RSI is set at 50.98 for Colgate-Palmolive Company [CL]. The present Moving Average for the last 50 days of trading for this stock 77.74, while it was recorded at 79.71 for the last single week of trading, and 78.48 for the last 200 days.
Colgate-Palmolive Company [CL]: A deeper dive into fundamental analysis
Operating Margin for any stock indicates how profitable investing would be, and Colgate-Palmolive Company [CL] shares currently have an operating margin of +22.31 and a Gross Margin at +59.08. Colgate-Palmolive Company’s Net Margin is presently recorded at +12.43.
Return on Equity for this stock inclined to 320.41, with Return on Assets sitting at 13.99.
Colgate-Palmolive Company’s liquidity data is similarly interesting compelling, with a Quick Ratio of 0.70 and a Current Ratio set at 1.10.
Colgate-Palmolive Company [CL]: An earnings per share (EPS) analysis
The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for CL. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Colgate-Palmolive Company go to 3.84%.
An analysis of insider ownership at Colgate-Palmolive Company [CL]
There are presently around $51,976 million, or 81.50% of CL stock, in the hands of institutional investors. The top three institutional holders of CL stocks are: VANGUARD GROUP INC with ownership of 77,195,703, which is approximately 0.585% of the company’s market cap and around 0.10% of the total institutional ownership; BLACKROCK INC., holding 66,575,004 shares of the stock with an approximate value of $5.24 billion in CL stocks shares; and STATE STREET CORP, currently with $3.9 billion in CL stock with ownership of nearly 0.648% of the company’s market capitalization.
Positions in Colgate-Palmolive Company stocks held by institutional investors increased at the end of July and at the time of the July reporting period, where 669 institutional holders increased their position in Colgate-Palmolive Company [NYSE:CL] by around 37,033,253 shares. Additionally, 780 investors decreased positions by around 36,339,437 shares, while 337 investors held positions by with 587,059,078 shares. The mentioned changes placed institutional holdings at 660,431,768 shares, according to the latest SEC report filing. CL stock had 103 new institutional investments in for a total of 3,783,689 shares, while 153 institutional investors sold positions of 1,806,458 shares during the same period.